ANXA5 and neoplasm: Targeting of externalised phosphatidylserines (PS) using annexin A5 (anxA5) is relatively unspecific because it will detect not only apoptotic cells but also, for instance, necrotic cells, ageing cells, hypoxic cardiomyocytes [1], tumour blood vessels and intravascular thrombi [2].